Semaglutide acts on GLP-1 receptors, which are involved in appetite regulation, glucose metabolism, and insulin response.

For this reason, lower-dose semaglutide may be considered as part of an individualized treatment plan focused on metabolic health.

However, the effects of a microdose may differ from those seen with standard therapeutic dosing, and individual response can vary.

These decisions are made independently by the provider and are based on their professional assessment of what is appropriate for your individual health needs.

Compounded medications are not FDA-approved. They are prepared by licensed compounding pharmacies under medical supervision and may differ in formulation, dosing, and supporting evidence from FDA-approved products.

This article is for general informational purposes only and does not provide medical advice, diagnosis or treatment for any specific person.